Liquid-liquid phase separation in hemoglobins: distinct aggregation mechanisms of the beta6 mutants.
Reversible liquid-liquid (L-L) phase separation in the form of high concentration hemoglobin (Hb) solution droplets is favored in an equilibrium with a low-concentration Hb solution when induced by inositol-hexaphosphate in the presence of polyethylene glycol 4000 at pH 6.35 HEPES (50 mM). The L-L phase separation of Hb serves as a model to elucidate intermolecular interactions that may give rise to accelerated nucleation kinetics of liganded HbC (beta6 Lys) compared to HbS (beta6 Val) and HbA (beta6 Glu). Under conditions of low pH (pH 6.35) in the presence of inositol-hexaphosphate, COHb assumes an altered R-state. The phase lines for the three Hb variants in concentration and temperature coordinates indicate that liganded HbC exhibits a stronger net intermolecular attraction with a longer range than liganded HbS and HbA. Over time, L-L phase separation gives rise to amorphous aggregation and subsequent formation of crystals of different kinetics and habits, unique to the individual Hb. The composite of R- and T-like solution aggregation behavior indicates that this is a conformationally driven event. These results indicate that specific contact sites, thermodynamics, and kinetics all play a role in L-L phase separation and differ for the beta6 mutant hemoglobins compared to HbA. In addition, the dense liquid droplet interface or aggregate interface noticeably participates in crystal nucleation.
Chen
Qiuying
Q
Department of Medicine, Division of Hematology, Albert Einstein College of Medicine, Bronx, New York, USA.
Vekilov
Peter G
PG
Nagel
Ronald L
RL
Hirsch
Rhoda Elison
RE
D019943:Amino Acid Substitution; D001665:Binding Sites; D003460:Crystallization / Q000379:methods*; D006454:Hemoglobins / Q000737:chemistry* / Q000648:ultrastructure*; D046911:Macromolecular Substances; D009154:Mutation; D044367:Phase Transition; D010833:Phytic Acid / Q000737:chemistry*; D011092:Polyethylene Glycols / Q000737:chemistry*; D011485:Protein Binding; D011487:Protein Conformation; D012995:Solubility; D012996:Solutions; D013329:Structure-Activity Relationship; D013696:Temperature
D006454:Hemoglobins; D046911:Macromolecular Substances; D012996:Solutions; D011092:Polyethylene Glycols; D010833:Phytic Acid